{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:18:50Z","timestamp":1791253130715,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1193648"],"award-info":[{"award-number":["APP1193648"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP 1176660"],"award-info":[{"award-number":["APP 1176660"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002337","name":"Petre Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022099","name":"Cerebral Palsy Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022099","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ebiom.2023.104589","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T06:55:29Z","timestamp":1682578529000},"page":"104589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["CSF neopterin, quinolinic acid and kynurenine\/tryptophan ratio are biomarkers of active neuroinflammation"],"prefix":"10.1016","volume":"91","author":[{"given":"Jingya","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavitha","family":"Kothur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekeeb","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrujna","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah F.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke A.","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velda X.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Ardern-Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayne","family":"Antony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj P.","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Tantsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tejaswi","family":"Kandula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Troedson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P Ian","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sekhar C.","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8866-9838","authenticated-orcid":false,"given":"Anna","family":"Guller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5000-4518","authenticated-orcid":false,"given":"Sushil","family":"Bandodkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-1826","authenticated-orcid":false,"given":"Russell C.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2023.104589_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2012.01.061","article-title":"Central nervous system inflammation in disease related conditions: mechanistic prospects","volume":"1446","author":"Fung","year":"2012","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104589_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/cmi.2016.58","article-title":"Cellular and molecular regulation of innate inflammatory responses","volume":"13","author":"Liu","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.ebiom.2023.104589_bib3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-neuro-110920-023056","article-title":"Microglia and neurodevelopmental disorders","volume":"45","author":"Lukens","year":"2022","journal-title":"Annu Rev Neurosci"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104589_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072431","article-title":"Exploring the etiological links behind neurodegenerative diseases: inflammatory cytokines and bioactive kynurenines","volume":"21","author":"Tanaka","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2023.104589_bib5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fnagi.2017.00208","article-title":"Microglial activation in traumatic brain injury","volume":"9","author":"Donat","year":"2017","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.ebiom.2023.104589_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/480739","article-title":"Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain","volume":"2013","author":"Ramesh","year":"2013","journal-title":"Mediat Inflamm"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104589_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161656","article-title":"Utility of CSF cytokine\/chemokines as markers of active intrathecal inflammation: comparison of demyelinating, anti-NMDAR and enteroviral encephalitis","volume":"11","author":"Kothur","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104589_bib8","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1097\/j.pain.0000000000001061","article-title":"High levels of cerebrospinal fluid chemokines point to the presence of neuroinflammation in peripheral neuropathic pain: a cross-sectional study of 2 cohorts of patients compared with healthy controls","volume":"158","author":"B\u00e4ckryd","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.ebiom.2023.104589_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fncel.2018.00072","article-title":"An inflammation-centric view of neurological disease: beyond the neuron","volume":"12","author":"Skaper","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104589_bib10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.autrev.2011.05.012","article-title":"Autoimmune disorders affecting both the central and peripheral nervous system","volume":"11","author":"Kamm","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2023.104589_bib11","first-page":"S232","article-title":"The role of inflammation in CNS injury and disease","volume":"147 Suppl 1","author":"Lucas","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104589_bib12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.7861\/clinmedicine.18-5-414","article-title":"Functional neurological disorders: acute presentations and management","volume":"18","author":"Cock","year":"2018","journal-title":"Clin Med"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104589_bib13","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/jnnp.56.11.1149","article-title":"Acute behaviour disturbances","volume":"56","author":"Lloyd","year":"1993","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104589_bib14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ebiom.2023.104589_bib15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"63","author":"Janka","year":"2012","journal-title":"Annu Rev Med"},{"issue":"23","key":"10.1016\/j.ebiom.2023.104589_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313127","article-title":"Current status of biomarkers in anti-N-Methyl-D-Aspartate receptor encephalitis","volume":"22","author":"Ciano-Petersen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ebiom.2023.104589_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.582296","article-title":"Cytokines\/chemokines: potential biomarkers for non-paraneoplastic anti-N-Methyl-D-Aspartate receptor encephalitis","volume":"11","author":"Liu","year":"2020","journal-title":"Front Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104589_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.autrev.2015.12.004","article-title":"Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination","volume":"15","author":"Ramanathan","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ebiom.2023.104589_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103984","article-title":"LC-MS biomarker diagnostics for neuroinflammatory disorders","volume":"78","author":"Morrens","year":"2022","journal-title":"eBioMedicine"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104589_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136981","article-title":"Neuroinflammation: a signature or a cause of epilepsy?","volume":"22","author":"Pracucci","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104589_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104589_bib22","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/epi.16275","article-title":"Etiology is the key determinant of neuroinflammation in epilepsy: elevation of cerebrospinal fluid cytokines and chemokines in febrile infection-related epilepsy syndrome and febrile status epilepticus","volume":"60","author":"Kothur","year":"2019","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104589_bib23","article-title":"Significance of blood and cerebrospinal fluid biomarkers for Alzheimer's disease: sensitivity, specificity and potential for clinical use","volume":"10","author":"d'Abramo","year":"2020","journal-title":"J\u00a0Personalized Med"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104589_bib24","first-page":"309","article-title":"The use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and research","volume":"38","author":"Kansal","year":"2015","journal-title":"Psychiatr Clin"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104589_bib25","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/INF.0000000000003085","article-title":"Bacterial meningitis in the absence of pleocytosis in children: a systematic review","volume":"40","author":"Zimmermann","year":"2021","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104589_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12974-019-1601-6","article-title":"Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases","volume":"16","author":"Lepennetier","year":"2019","journal-title":"J\u00a0Neuroinflammation"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104589_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1469-8749.2008.03225.x","article-title":"Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation","volume":"51","author":"Dale","year":"2009","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104589_bib28","doi-asserted-by":"crossref","first-page":"e1318","DOI":"10.1002\/cti2.1318","article-title":"Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease","volume":"10","author":"Yan","year":"2021","journal-title":"Clin Transl Immunol"},{"issue":"24","key":"10.1016\/j.ebiom.2023.104589_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249338","article-title":"Searching for peripheral biomarkers in neurodegenerative diseases: the tryptophan-kynurenine metabolic pathway","volume":"21","author":"T\u00f6r\u00f6k","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"17","key":"10.1016\/j.ebiom.2023.104589_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179968","article-title":"The role of tryptophan metabolites in neuropsychiatric disorders","volume":"23","author":"Davidson","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104589_bib31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/1673-5374.198971","article-title":"Kynurenine pathway metabolism and neuroinflammatory disease","volume":"12","author":"Braidy","year":"2017","journal-title":"Neural Regen Res"},{"issue":"13","key":"10.1016\/j.ebiom.2023.104589_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23136991","article-title":"Editorial of special issue 'dissecting neurological and neuropsychiatric diseases: neurodegeneration and neuroprotection'","volume":"23","author":"Tanaka","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"16","key":"10.1016\/j.ebiom.2023.104589_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162607","article-title":"Mitochondrial impairment: a common motif in neuropsychiatric presentation? The link to the tryptophan-kynurenine metabolic system","volume":"11","author":"Tanaka","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ebiom.2023.104589_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103917","article-title":"Development of a translational inflammation panel for the quantification of cerebrospinal fluid Pterin, Tryptophan-Kynurenine and Nitric oxide pathway metabolites","volume":"77","author":"Yan","year":"2022","journal-title":"eBioMedicine"},{"issue":"5","key":"10.1016\/j.ebiom.2023.104589_bib35","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/dmcn.14774","article-title":"Cerebrospinal fluid metabolites in tryptophan-kynurenine and nitric oxide pathways: biomarkers for acute neuroinflammation","volume":"63","author":"Yan","year":"2021","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104589_bib36","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/cid\/cit458","article-title":"Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium","volume":"57","author":"Venkatesan","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104589_bib37","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult Scler"},{"issue":"Pt B","key":"10.1016\/j.ebiom.2023.104589_bib38","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neuropharm.2016.03.024","article-title":"Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases","volume":"112","author":"Lovelace","year":"2017","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104589_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061548","article-title":"Neuroinflammation and the kynurenine pathway in CNS disease: molecular mechanisms and therapeutic implications","volume":"10","author":"Mithaiwala","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104589_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-018-0304-2","article-title":"Recent advances and perspectives of metabolomics-based investigations in Parkinson's disease","volume":"14","author":"Shao","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"2","key":"10.1016\/j.ebiom.2023.104589_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10020051","article-title":"Toward a standardized strategy of clinical metabolomics for the advancement of precision medicine","volume":"10","author":"Long","year":"2020","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104589_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinf"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104589_bib43","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"18","key":"10.1016\/j.ebiom.2023.104589_bib44","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006686","article-title":"Cerebrospinal fluid pleocytosis in infectious and noninfectious central nervous system disease: a retrospective cohort study","volume":"96","author":"Baunb\u00e6k Egelund","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.ebiom.2023.104589_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12907-017-0053-0","article-title":"Cerebrospinal fluid pleocytosis level as a diagnostic predictor? A cross-sectional study","volume":"17","author":"\u00d8stergaard","year":"2017","journal-title":"BMC Clin Pathol"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104589_bib46","article-title":"Neopterin, inflammation, and oxidative stress: what could we Be missing?","volume":"7","author":"Gieseg","year":"2018","journal-title":"Antioxidants (Basel)"},{"issue":"7","key":"10.1016\/j.ebiom.2023.104589_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9070734","article-title":"Immune influencers in action: metabolites and enzymes of the tryptophan-kynurenine metabolic pathway","volume":"9","author":"Tanaka","year":"2021","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104589_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030564","article-title":"Are kynurenines accomplices or principal villains in dementia? Maintenance of kynurenine metabolism","volume":"25","author":"Tanaka","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104589_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/cells12030460","article-title":"Kynurenine pathway in diabetes mellitus-novel pharmacological target?","volume":"12","author":"Kozie\u0142","year":"2023","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104589_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.17219\/acem\/139572","article-title":"Monitoring the kynurenine system: concentrations, ratios or what else?","volume":"30","author":"Tanaka","year":"2021","journal-title":"Adv Clin Exp Med"},{"issue":"4","key":"10.1016\/j.ebiom.2023.104589_bib51","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.ebiom.2023.104589_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104280","article-title":"Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: a biomarker of response to corticosteroids","volume":"84","author":"Yan","year":"2022","journal-title":"eBioMedicine"},{"issue":"8","key":"10.1016\/j.ebiom.2023.104589_bib53","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"279","author":"Guillemin","year":"2012","journal-title":"FEBS J"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104589_bib54","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00004647-199806000-00002","article-title":"Quinolinic acid is increased in CSF and associated with mortality after traumatic brain injury in humans","volume":"18","author":"Sinz","year":"1998","journal-title":"J\u00a0Cereb Blood Flow Metab"},{"issue":"Pt 5","key":"10.1016\/j.ebiom.2023.104589_bib55","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/brain\/124.5.1033","article-title":"Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection","volume":"124","author":"Heyes","year":"2001","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2023.104589_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577088","article-title":"Elevated quinolinic acid levels in cerebrospinal fluid in subacute sclerosing panencephalitis","volume":"339","author":"Inoue","year":"2020","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.ebiom.2023.104589_bib57","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12974-015-0328-2","article-title":"Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans","volume":"12","author":"Yan","year":"2015","journal-title":"J\u00a0Neuroinflammation"},{"issue":"1","key":"10.1016\/j.ebiom.2023.104589_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/glia.20090","article-title":"Expression of\u00a0indoleamine 2,3-dioxygenase and production of quinolinic acid\u00a0by human microglia, astrocytes, and neurons","volume":"49","author":"Guillemin","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.ebiom.2023.104589_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/104024","article-title":"Quinolinic acid: an endogenous neurotoxin with multiple targets","volume":"2013","author":"Lugo-Huitr\u00f3n","year":"2013","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104589_bib60","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0031-6997(25)00441-7","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol Rev"},{"issue":"11","key":"10.1016\/j.ebiom.2023.104589_bib61","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ebiom.2023.104589_bib62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cyto.2015.10.001","article-title":"CSF cytokines\/chemokines as biomarkers in neuroinflammatory CNS disorders: a systematic review","volume":"77","author":"Kothur","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.ebiom.2023.104589_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.646043","article-title":"Systems-Level proteomics evaluation of microglia response to tumor-supportive anti-inflammatory cytokines","volume":"12","author":"Ahuja","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104589_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.644725","article-title":"From ELISA to immunosorbent tandem mass spectrometry proteoform analysis: the example of CXCL8\/interleukin-8","volume":"12","author":"Metzemaekers","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.ebiom.2023.104589_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122697","article-title":"Advances in proteomic techniques for cytokine analysis: focus on melanoma research","volume":"18","author":"Kupcova Skalnikova","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.ebiom.2023.104589_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108826","article-title":"Proteomics reveals distinct mechanisms regulating the release of cytokines and alarmins during pyroptosis","volume":"34","author":"Phulphagar","year":"2021","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2023.104589_bib67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.tim.2012.03.009","article-title":"Viral disruption of the blood-brain barrier","volume":"20","author":"Spindler","year":"2012","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.ebiom.2023.104589_bib68","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ebiom.2023.104589_bib69","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3389\/fimmu.2017.01957","article-title":"Kynurenic acid: the janus-faced role of an immunomodulatory tryptophan metabolite and its link to pathological conditions","volume":"8","author":"Wirthgen","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104589_bib70","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.3389\/fimmu.2019.02565","article-title":"Tryptophan metabolism in inflammaging: from biomarker to therapeutic target","volume":"10","author":"Sorgdrager","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104589_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.860867","article-title":"Editorial: multiple implications of the kynurenine pathway in inflammatory diseases: diagnostic and therapeutic applications","volume":"13","author":"M\u00e1ndi","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2023.104589_bib72","article-title":"Recent advances in clinical trials targeting the kynurenine pathway","volume":"236","author":"Pires","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ebiom.2023.104589_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103833","article-title":"Seizure modulation by the gut microbiota and tryptophan-kynurenine metabolism in an animal model of infantile spasms","volume":"76","author":"Mu","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2023.104589_bib74","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jnutbio.2018.07.010","article-title":"Gut microbes as future therapeutics in treating inflammatory and infectious diseases: lessons from recent findings","volume":"61","author":"Mukherjee","year":"2018","journal-title":"J\u00a0Nutr Biochem"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423001548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423001548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:36:15Z","timestamp":1778873775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423001548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":74,"alternative-id":["S2352396423001548"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104589","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF neopterin, quinolinic acid and kynurenine\/tryptophan ratio are biomarkers of active neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104589","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104589"}}